geranylgeraniol has been researched along with Rheumatoid Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, S; Connor, AM; Keystone, EC; Narendran, A | 1 |
| Harten, SK; Haskard, DO; Johns, M; Kinderlerer, AR; Lidington, EA; Mason, JC; Maxwell, PH; Steinberg, R | 1 |
2 other study(ies) available for geranylgeraniol and Rheumatoid Arthritis
| Article | Year |
|---|---|
Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts.
Topics: Apoptosis; Arthritis, Rheumatoid; Biological Transport; Cell Survival; Cells, Cultured; Cytoplasm; Diterpenes; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Membrane Proteins; Osteoarthritis; Polyisoprenyl Phosphates; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; RNA, Small Interfering; Synovial Membrane; Tissue Distribution; Tumor Necrosis Factor-alpha | 2006 |
Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atorvastatin; CD55 Antigens; CD59 Antigens; Cells, Cultured; Cobalt; Cytoprotection; Deferoxamine; Diterpenes; Endothelial Cells; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Iron Chelating Agents; Mevalonic Acid; Pyrroles; RNA, Messenger; Up-Regulation | 2006 |